Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04257110
Title A First-in-human Study of Multiple Doses of BB-1701 in Subjects With Locally Advanced/Metastatic HER2 Expressing Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bliss Biopharmaceutical (Hangzhou) Co., Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94158 United States Details
Sarah Cannon Research Nashville Tennessee 37203 United States Details
The Regents of NEXT Virginia, LLC Fairfax Virginia 22031 United States Details
Jiangsu Province Hospital Nanjin Jiangsu China Details
Tianjin Medical University Cancer Institute and Hospital Tianjin Tianjin China Details
Cancer Hospital Chinese Academy of Medical Science Beijing 100021 China Details
Sun Yat-sen Memorial Hospital Guangzhou China Details
The First Affiliated Hospital of Zhejiang University Hangzhou 310003 China Details
Sir Run Run Shaw Hospital - Zhejiang University School of Medicine Hangzhou China Details
Zhejiang Cancer Hospital Hanzhou China Details
Linyi Cancer Hospital Linyi China Details
Hubei Cancer Hospital Wuhan China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field